Claus Yding Andersen

ORCID: 0000-0001-7681-253X · 13 papers in corpus
rct 2022
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deac061

STUDY QUESTION: Does addition of choriogonadotropin beta (recombinant CG beta) to follitropin delta increase the number of good-quality blastocysts following ovarian stimulation in a long GnRH agonist protocol? SUMMARY ANSWER: At the doses…

rct 2022
Frontiers in endocrinology ·doi:10.3389/fendo.2022.1004596

BACKGROUND: Choriogonadotropin (CG) beta (FE 999302), a novel recombinant human (h)CG produced by a human cell line, has a longer half-life and higher potency than CG alfa produced by a Chinese hamster ovary cell line. hCG augments steroid …

other 2020
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-020-00605-z

The prolonged lockdown of health services providing high-complexity fertility treatments -as currently recommended by many reproductive medicine entities- is detrimental for society as a whole, and infertility patients in particular. Global…

observational 2020
Frontiers in endocrinology ·doi:10.3389/fendo.2020.00137

Introduction: It has recently been shown that late follicular phase progesterone levels correlate well with those in the early luteal phase, and that progesterone levels before and 12 h after human chorionic gonadotropin (hCG) administratio…

observational 2020
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-019-01633-4

PURPOSE: To evaluate the association between anti-Müllerian hormone (AMH) and follicle density in infertile women with diminished ovarian reserve (DOR) versus women with normal ovarian reserve? METHODS: Case-control study comparing follicl…

other 2019
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-019-01432-x

PURPOSE: The IGF signaling cascade exerts important regulatory functions in human ovarian folliculogenesis. The scope of this study was to evaluate the transcription profile of insulin-like growth factor (IGF) genes during human ovarian fol…

other 2018
Frontiers in endocrinology ·doi:10.3389/fendo.2018.00092

OBJECTIVE: To investigate whether mid-luteal serum progesterone (P4) exhibits significant fluctuations during a 12-h daytime period in women undergoing in vitro fertilization (IVF) and to explore whether the extent of these fluctuations cou…

2018
Frontiers in endocrinology ·doi:10.3389/fendo.2018.00690

Introduction: Corpus luteum (CL) produces progesterone (P4) and 17-OH progesterone (17-OH P4) during the luteal phase. Contrary to P4, 17-OH P4 is not supplied as part of the luteal phase support following IVF-treatment. Therefore, measurin…

other 2015
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2015.08.014
case-report 2014
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-014-0331-z

PURPOSE: To report another two successful pregnancies and deliveries resulting from autotransplanted cryopreserved ovarian tissue several years after the autotransplantation procedure took place. Further, to review the literature on the tre…

other 2013
Reproductive biology and endocrinology : RB&E ·doi:10.1186/1477-7827-11-51

BACKGROUND: V-betaLH is a common genetic variant of LH caused by two polymorphic base changes in the beta subunit gene, altering the amino acid sequence (Trp8Arg and Ile15Thr). In a previous-preliminary trial performed in women undergoing I…

nonrandomized-trial 2009
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2009.02.001

OBJECTIVE: The key enzyme in the biosynthesis of estradiol, aromatase, has been demonstrated within endometriosis. Combined administration of aromatase inhibitor and GnRH-agonist may efficiently suppress estrogen biosynthesis through a comb…

review 1993
Ugeskrift for laeger

Medical indications for in vitro fertilization and embryo transfer (IVF-ET) internationally and in Denmark are reviewed. Reports from large international centres document that tubal infertility, unexplained infertility, endometriosis and ma…